| Bioactivity | GSK376501A is a selective peroxisome proliferator-activated receptor gamma (PPARγ) modulator for the treatment of type 2 diabetes mellitus[1]. | ||||||||||||
| Name | GSK376501A | ||||||||||||
| CAS | 1010412-80-2 | ||||||||||||
| Formula | C32H37NO6 | ||||||||||||
| Molar Mass | 531.64 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Kae M. Bullock, et al. Process Development and Scale-Up of a PPARγ Agonist: Selection of the Manufacture Route. Org. Process Res. Dev. 2009, 13, 2, 303-309. |